Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis

Journal of Neuroimmunology

Volumn 171, Issue 1-2, 2006, Pages 163-170

  Okuda, Yoshinobu ^a,b,c   Apatoff, Brian R ^a   Posnett, David N ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c University of Occupational and Environmental Health   (Japan)

Author keywords

Apoptosis; CD4+ T cells; CD8+ T cells; Fas; Five color flow cytometry; Multiple sclerosis

Indexed keywords

FAS ANTIGEN; LIPOCORTIN 5;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLOOD; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BINDING; REMISSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ADULT; ANNEXIN A5; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; CASE-CONTROL STUDIES; CEREBROSPINAL FLUID; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 29244464322     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.09.020     Document Type: Article

References (39)

1. A. Achiron, M. Gurevich, N. Friedman, N. Kaminski, and M. Mandel Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity Ann. Neurol. 55 2004 410 417
2. + T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis J. Clin. Invest. 95 1995 2711 2719
3. M. Bilinska, I. Frydecka, R. Podemski, and E. Gruszka Fas expression on T cells and sFas in relapsing-remitting multiple sclerosis Acta Neurol. Scand. 107 2003 387 393
4. Y. Chen, W.W. Hancock, R. Marks, P. Gonnella, and H.L. Weiner Mechanism of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice J. Neuroimmunol. 82 1998 149 159
5. E. Ciusani, S. Frigerio, M. Gelati, E. Corsini, A. Dufour, A. Nespolo, L. La Mantia, C. Milanese, G. Massa, and A. Salmaggi Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients J. Neuroimmunol. 82 1998 5 12
6. C. Comi, M. Leone, S. Bonissoni, S. DeFranco, F. Bottarel, C. Mezzatesta, A. Chiocchetti, F. Perla, F. Monaco, and U. Dianzani Defective T cell Fas function in patients with multiple sclerosis Neurology 55 2000 921 927
7. + regulatory thymocytes Blood 102 2003 4107 4114
8. + T suppressor cells are back to the game: are they players in autoimmunity? Autoimmun. Rev. 1 2002 279 283
9. A.C. Gomes, M. Morris, L. Stawiarz, G. Jonsson, P. Putheti, L. Bronge, H. Link, and J. Hillert Decreased levels of CD95 and caspase-8 mRNA in multiple sclerosis patients with gadolinium-enhancing lesions on MRI Neurosci. Lett. 4 2003 101 104
10. P. Gniadek, O. Aktas, K.P. Wandinger, J. Bellmann-Strobl, O. Wengert, A. Weber, P. von Wussow, H.J. Obert, and F. Zipp Systemic IFN-beta treatment induces apoptosis of peripheral immune cells in MS patients J. Neuroimmunol. 137 2003 187 196
11. H.J. Hasper, R.M. Weghorst, D.J. Richel, J.H. Meerwaldt, F.M. Olthuis, and C.E. Schenkeveld A new four-color flow cytometric assay to detect apoptosis in lymphocyte subsets of cultured peripheral blood cells Cytometry 40 2000 167 171
12. W.-X. Huang, M.P. Huang, M.A. Gomes, and J. Hillert Apoptosis mediators FasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS Neurology 55 2000 928 934
13. H. Ichikawa, K. Ota, and M. Iwata Increased Fas antigen on T cells in multiple sclerosis J. Neuroimmunol. 71 1996 125 129
14. O.H. Kantarci, D.D. Hebrink, S.J. Achenbach, E.J. Atkinson, M. de Andrade, C.T. McMurray, and B.G. Weinshenker CD95 polymorphisms are associated with susceptibility to MS in women. A population-based study of CD95 and CD95L in MS J. Neuroimmunol. 146 2004 162 170
15. (+) T cell responses in patients with multiple sclerosis J. Clin. Invest. 109 2002 641 649
16. + T lymphocytopenia J. Clin. Invest. 97 1996 672 680
17. J. Lieberman The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal Nat. Rev., Immunol. 3 2003 361 370
18. L. Lopatinskaya, A.H. van Boxel-Dezaire, F. Barkhof, C.H. Polman, C.J. Lucas, and L. Nagelkerken The development of clinical activity in relapsing-remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood J. Neuroimmunol. 138 2003 123 131
19. B. Macchi, C. Matteucci, U. Nocentini, C. Caltagirone, and A. Mastino Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis Neuroreport 10 1999 399 402
20. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.-P. Hartung, F.D. Lublin, H.F. McFarland, D.W. Paty, C.H. Polman, S.C. Reingold, M. Sandberg-Wollheim, W. Sibley, A. Thompson, S. van den Noort, B.Y. Weinshenker, and J.S. Wolinsky Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann. Neurol. 50 2001 121 127
21. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker Multiple sclerosis N. Engl. J. Med. 343 2000 938 952
22. Y. Okuda, S. Sakoda, H. Fujimura, and T. Yanagihara Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis J. Neuroimmunol. 73 1997 107 116
23. Y. Okuda, S. Sakoda, H. Fujimura, and T. Yanagihara The effect of apoptosis inhibitors on experimental autoimmune encephalomyelitis: apoptosis as a regulatory factor Biochem. Biophys. Res. Commun. 267 2000 826 830
24. Y. Okuda, M. Okuda, and C.C. Bernard The suppression of T cell apoptosis influences the severity of disease during the chronic phase but not the recovery from the acute phase of experimental autoimmune encephalomyelitis in mice J. Neuroimmunol. 131 2002 115 125
25. + T cells in patients with multiple sclerosis J. Neurol. Sci. 235 2005 11 17
26. M.P. Pender Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis Lancet 351 1998 978 981
27. + T cells by immunomodulatory therapy of multiple sclerosis with glatiramer acetate Eur. Neurol. 50 2003 200 206
28. + T lymphocytopenia Clin. Infect. Dis. 28 1999 1012 1016
29. M. Schmied, H. Breitschopf, R. Gold, H. Zischler, G. Rothe, H. Wekerle, and H. Lassmann Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis Am. J. Pathol. 143 1993 446 452
30. Y.K. Semra, O.A. Seidi, and M.K. Sharief Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins J. Neuroimmunol. 122 2002 159 166
31. M.K. Sharief Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis J. Neuroimmunol. 109 2000 236 243
32. M.K. Sharief, M.A. Noori, and Y. Zoukos Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy J. Neuroimmunol. 129 2002 224 231
33. M.K. Sharief, H. Matthews, and M.A. Noori Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis J. Neuroimmunol. 134 2003 158 165
34. Z. Tabi, P.A. McCombe, and M.P. Pender Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system Int. Immunol. 7 1995 967 973
35. Y.C. Zang, M.M. Kozovska, J. Hong, S. Li, S. Mann, J.M. Killian, V.M. Rivera, and J.Z. Zhang Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis Eur. J. Immunol. 29 1999 1692 1700
36. + T cells as a mechanism for remission from experimental allergic encephalomyelitis J. Neuroimmunol. 44 1993 193 198
37. F. Zipp, K. Otzelberger, J. Dichgans, R. Martin, and M. Weller Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis J. Neuroimmunol. 86 1998 151 154
38. F. Zipp, E. Faber, N. Sommer, C. Muller, J. Dichgans, P.H. Krammer, R. Martin, and M. Weller CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2 J. Neuroimmunol. 81 1998 168 172
39. T. Zhou, L. Song, P. Yang, Z. Wang, D. Lui, and R.S. Jope Bisindolymaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases Nat. Med. 5 1999 42 48